- Home
- HURC vs LPTX Comparison
HURC vs LPTX Comparison
Compare HURC & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- LPTX
- Stock Information
- Founded
- HURC 1968
- LPTX 2011
- Country
- HURC United States
- LPTX United States
- Employees
- HURC N/A
- LPTX N/A
- Industry
- HURC Industrial Machinery/Components
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HURC Industrials
- LPTX Health Care
- Exchange
- HURC Nasdaq
- LPTX Nasdaq
- Market Cap
- HURC 102.5M
- LPTX 119.6M
- IPO Year
- HURC N/A
- LPTX N/A
- Fundamental
- Price
- HURC $15.58
- LPTX $0.38
- Analyst Decision
- HURC
- LPTX Buy
- Analyst Count
- HURC 0
- LPTX 2
- Target Price
- HURC N/A
- LPTX $8.00
- AVG Volume (30 Days)
- HURC 32.1K
- LPTX 321.1K
- Earning Date
- HURC 06-06-2025
- LPTX 08-11-2025
- Dividend Yield
- HURC N/A
- LPTX N/A
- EPS Growth
- HURC N/A
- LPTX N/A
- EPS
- HURC N/A
- LPTX N/A
- Revenue
- HURC $183,634,000.00
- LPTX N/A
- Revenue This Year
- HURC N/A
- LPTX N/A
- Revenue Next Year
- HURC N/A
- LPTX N/A
- P/E Ratio
- HURC N/A
- LPTX N/A
- Revenue Growth
- HURC N/A
- LPTX N/A
- 52 Week Low
- HURC $13.19
- LPTX $0.22
- 52 Week High
- HURC $23.76
- LPTX $4.79
- Technical
- Relative Strength Index (RSI)
- HURC 58.12
- LPTX 46.09
- Support Level
- HURC $14.25
- LPTX $0.38
- Resistance Level
- HURC $15.31
- LPTX $0.44
- Average True Range (ATR)
- HURC 0.64
- LPTX 0.04
- MACD
- HURC 0.15
- LPTX -0.00
- Stochastic Oscillator
- HURC 100.00
- LPTX 22.52
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .